Lumakras, Sotorasib 120 mg film-coated tablets, 56 tablets — generic For the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with the KRAS G12C mutation. Drug delivery from Europe: +380996042415, Viber, WhatsApp.

Indications for the active substance SOTORASIB

As monotherapy for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with the KRAS G12C mutation who have progressed after at least one prior line of systemic therapy.